Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Angelika Duda"'
Autor:
Maren Hedtke, Rodrigo Pessoa Rejas, Matthias F. Froelich, Volker Ast, Angelika Duda, Laura Mirbach, Victor Costina, Uwe M. Martens, Ralf‐Dieter Hofheinz, Michael Neumaier, Verena Haselmann
Publikováno v:
Molecular Oncology, Vol 16, Iss 10, Pp 2042-2056 (2022)
The analysis of circulating tumor DNA (ctDNA) is at the threshold of implementation into standard care for colorectal cancer (CRC) patients. However, data about the clinical utility of liquid profiling (LP), its acceptance by clinicians, and its inte
Externí odkaz:
https://doaj.org/article/c1e5149860064c5e8fd192d932a6be65
Autor:
Maren Hedtke, Rodrigo Pessoa Rejas, Matthias F. Froelich, Volker Ast, Angelika Duda, Laura Mirbach, Victor Costina, Uwe M. Martens, Ralf‐Dieter Hofheinz, Michael Neumaier, Verena Haselmann
Publikováno v:
Molecular Oncology. 16:2042-2056
The analysis of circulating tumor DNA (ctDNA) is at the threshold of implementation into standard care for colorectal cancer (CRC) patients. However, data about the clinical utility of liquid profiling (LP), its acceptance by clinicians, and its inte
Autor:
null Maren Hedtke, null Rodrigo Pessoa Rejas, null Matthias F. Froelich, null Volker Ast, null Angelika Duda, null Laura Mirbach, null Victor Costina, null Uwe M. Martens, null Ralf‐Dieter Hofheinz, null Michael Neumaier, null Verena Haselmann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dea1dfd5ffc6ad950b245bd78118c0f6
https://doi.org/10.1002/1878-0261.13156/v2/response1
https://doi.org/10.1002/1878-0261.13156/v2/response1
Autor:
Jochen Utikal, Michael Neumaier, Verena Haselmann, Eleni Tzanikou, Angelika Duda, Athina Markou, Evi Lianidou
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 58(11)
Background In metastatic melanoma, 40%–50% of patients harbor a BRAF V600E mutation and are thereby eligible to receive a combined BRAF/MEK inhibitor therapy. Compared to standard-of-care tissue-based genetic testing, analysis of circulating tumor
Publikováno v:
Open Geosciences, Vol 10, Iss 1, Pp 474-483 (2018)
The aim of the study was to find the best model of ground-motion prediction equation (GMPE) forecasting peak ground acceleration (PGA) caused by induced seismicity. The maximum values of PGA on the surface are a major seismic threat for the infrastru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbba57ab987c2bbe68d811be8eb26dce
http://hdl.handle.net/20.500.12128/6498
http://hdl.handle.net/20.500.12128/6498
Autor:
Angelika Duda, Jochen Utikal, Dirk Schadendorf, Verena Haselmann, Antje Sucker, Ingrid Brechtel, Michael Neumaier, Claudia Czerwinski, Tim Holland-Letz, Christoffer Gebhardt
Publikováno v:
Clinical chemistry. 64(5)
BACKGROUND The current standard for determining eligibility of patients with metastatic melanoma for BRAF-targeted therapy is tissue-based testing of BRAF mutations. As patients are rarely rebiopsied, detection in blood might be advantageous by enabl
Autor:
Michael Neumaier, Angelika Duda, Romy Eichner, Merle Gabor, Parviz Ahmad-Nejad, Simon Patton, Wolf J. Geilenkeuser, Verena Haselmann
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 56(2)
Background:Circulating tumour DNA (ctDNA) is considered to have a high potential for future management of malignancies. This pilot external quality assessment (EQA) scheme aimed to address issues of analytical quality in this new area of laboratory d
Autor:
Antje Sucker, Peter Bronsert, Bastian Malzkorn, Angelika Duda, Martin Werner, Martina Oberländer, Hans-Peter Bruch, Guido Reifenberger, Dirk Schadendorf, Michael Linnebacher, Elmar Stickeler, Jens K. Habermann, Parviz Ahmad-Nejad, Michael Neumaier
Biobanks are becoming increasingly important for assessment of disease risk as well as identification and validation of new diagnostic biomarkers and druggable targets. The validity of data obtained from biobanks is critically limited by the biomater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0c22c6f0f0f4133dca0093273870bc
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84946838768
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84946838768